{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:37:00Z","timestamp":1792467420258,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejphar.2020.173685","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T12:44:02Z","timestamp":1603802642000},"page":"173685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["LL-00066471, a novel positive allosteric modulator of \u03b17 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization"],"prefix":"10.1016","volume":"891","author":[{"given":"Mahip K.","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan N.","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand M.","family":"Bokare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj P.","family":"Dandekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Koul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santoshkumar","family":"Tota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant B.","family":"Nigade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod B.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayasagar","family":"Gundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer S.","family":"Walunj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navnath P.","family":"Karche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelima","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajender K.","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata P.","family":"Palle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173685_bib1","first-page":"1","article-title":"Selective alpha7 nicotinic receptor agonists and positive allosteric modulators for the treatment of schizophrenia - a review","author":"Antonio-Tolentino","year":"2020","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2020.173685_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cognit. Process."},{"key":"10.1016\/j.ejphar.2020.173685_bib3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia: review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2020.173685_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2215-0366(17)30040-8","article-title":"Cognition in psychiatric disorders: from models to management","volume":"4","author":"Berk","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ejphar.2020.173685_bib5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1124\/pr.113.008581","article-title":"Therapeutic potential of alpha7 nicotinic acetylcholine receptors","volume":"67","author":"Bertrand","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2020.173685_bib6","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1523\/JNEUROSCI.2444-07.2007","article-title":"Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1\/2 and CREB phosphorylation pathways","volume":"27","author":"Bitner","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173685_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.110.167213","article-title":"In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease","volume":"334","author":"Bitner","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173685_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2012.10.019","article-title":"Positive allosteric modulator of alpha7 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates","volume":"67","author":"Callahan","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173685_bib9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuropharm.2017.02.025","article-title":"Tropisetron sensitizes alpha7 containing nicotinic receptors to low levels of acetylcholine in vitro and improves memory-related task performance in young and aged animals","volume":"117","author":"Callahan","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173685_bib10","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.cub.2013.07.002","article-title":"The rodent hippocampus is essential for nonspatial object memory","volume":"23","author":"Cohen","year":"2013","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2020.173685_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","article-title":"Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system","volume":"47","author":"Dani","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2020.173685_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1586\/14737175.2015.995639","article-title":"Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication","volume":"15","author":"Deardorff","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejphar.2020.173685_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/7854_2020_136","article-title":"An evolving therapeutic rationale for targeting the alpha7 nicotinic acetylcholine receptor in autism spectrum disorder","volume":"45","author":"Deutsch","year":"2020","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.ejphar.2020.173685_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tips.2014.12.002","article-title":"Nicotinic ACh receptors as therapeutic targets in CNS disorders","volume":"36","author":"Dineley","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2020.173685_bib15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/jpet.110.173245","article-title":"Characterization of 2-[[4-fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a novel positive allosteric modulator of the {alpha}7 nicotinic acetylcholine receptor","volume":"336","author":"Dinklo","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173685_bib16","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1021\/jm9003818","article-title":"Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor","volume":"52","author":"Faghih","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173685_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1601-183X.2005.00176.x","article-title":"Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working\/episodic-like memory","volume":"5","author":"Fernandes","year":"2006","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.ejphar.2020.173685_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1874609811003010046","article-title":"Treatment of Alzheimer's disease: symptomatic and disease-modifying approaches","volume":"3","author":"Galimberti","year":"2010","journal-title":"Curr. Aging Sci."},{"key":"10.1016\/j.ejphar.2020.173685_bib19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/0269881117691590","article-title":"First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288","volume":"31","author":"Gee","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2020.173685_bib20","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1097\/00001756-199906030-00028","article-title":"Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain","volume":"10","author":"Guan","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2020.173685_bib21","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1038\/npp.2016.101","article-title":"The alpha7 nicotinic agonist ABT-126 in the treatment of cognitive impairment associated with schizophrenia in nonsmokers: results from a randomized controlled phase 2b study","volume":"41","author":"Haig","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2020.173685_bib22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/jnc.12817","article-title":"Alpha-7 nicotinic acetylcholine receptor agonist treatment reduces neuroinflammation, oxidative stress, and brain injury in mice with ischemic stroke and bone fracture","volume":"131","author":"Han","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2020.173685_bib23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/acsmedchemlett.9b00001","article-title":"Discovery of BNC375, a potent, selective, and orally available type I positive allosteric modulator of alpha7 nAChRs","volume":"10","author":"Harvey","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2020.173685_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biopsych.2007.04.034","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711","volume":"63","author":"Hashimoto","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2020.173685_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bcp.2009.05.030","article-title":"TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia","volume":"78","author":"Hauser","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173685_bib26","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1523\/JNEUROSCI.5038-09.2010","article-title":"Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease","volume":"30","author":"Hernandez","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173685_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00213-006-0549-2","article-title":"Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task","volume":"189","author":"Hoyle","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2020.173685_bib28","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1476-5381.2009.00474.x","article-title":"Positive allosteric modulation of alpha7 neuronal nicotinic acetylcholine receptors: lack of cytotoxicity in PC12 cells and rat primary cortical neurons","volume":"158","author":"Hu","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173685_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0891-0618(01)00101-6","article-title":"Cholinergic systems and schizophrenia: primary pathology or epiphenomena?","volume":"22","author":"Hyde","year":"2001","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ejphar.2020.173685_bib30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/npp.2017.182","article-title":"Pharmacokinetic limitations on effects of an alpha7-nicotinic receptor agonist in schizophrenia: randomized trial with an extended-release formulation","volume":"43","author":"Kem","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2020.173685_bib31","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hipo.22615","article-title":"Detecting and discriminating novel objects: the impact of perirhinal cortex disconnection on hippocampal activity patterns","volume":"26","author":"Kinnavane","year":"2016","journal-title":"Hippocampus"},{"key":"10.1016\/j.ejphar.2020.173685_bib32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41582-018-0070-3","article-title":"Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease","volume":"14","author":"Kivipelto","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2020.173685_bib33","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pharmthera.2009.03.009","article-title":"A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits","volume":"122","author":"Leiser","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2020.173685_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainresbull.2012.11.003","article-title":"alpha7 nicotinic acetylcholine receptors and their role in cognition","volume":"93","author":"Lendvai","year":"2013","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2020.173685_bib35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/1568007023339102","article-title":"Nicotinic treatment for cognitive dysfunction","volume":"1","author":"Levin","year":"2002","journal-title":"Curr. Drug Targets - CNS Neurol. Disord."},{"key":"10.1016\/j.ejphar.2020.173685_bib36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.108.136580","article-title":"ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1- yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities","volume":"327","author":"Liu","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173685_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fphar.2019.00153","article-title":"Critical role of Nrf2 in experimental ischemic stroke","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173685_bib38","first-page":"6072","article-title":"Nicotinic acetylcholine receptor Alpha7 subunit mediates vagus nerve stimulation-induced neuroprotection in acute permanent cerebral ischemia by a7nAchR\/JAK2 pathway","volume":"23","author":"Lu","year":"2017","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.ejphar.2020.173685_bib39","doi-asserted-by":"crossref","first-page":"12375","DOI":"10.1073\/pnas.220398097","article-title":"The visual paired-comparison task as a measure of declarative memory","volume":"97","author":"Manns","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173685_bib40","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1177\/0269881111431747","article-title":"PNU-120596, a positive allosteric modulator of alpha7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats","volume":"26","author":"McLean","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2020.173685_bib41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuropharm.2015.07.034","article-title":"Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats","volume":"101","author":"Nikiforuk","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173685_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2014.01.029","article-title":"Merging old and new perspectives on nicotinic acetylcholine receptors","volume":"89","author":"Papke","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173685_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5853\/jos.2016.01515","article-title":"Strategies to extend thrombolytic time window for ischemic stroke treatment: an unmet clinical need","volume":"19","author":"Pena","year":"2017","journal-title":"J Stroke"},{"key":"10.1016\/j.ejphar.2020.173685_bib44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/7854_2011_195","article-title":"Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders","volume":"12","author":"Powell","year":"2012","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.ejphar.2020.173685_bib45","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neuropharm.2011.10.024","article-title":"EVP-6124, a novel and selective alpha7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of alpha7 nicotinic acetylcholine receptors","volume":"62","author":"Prickaerts","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173685_bib46","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.2174\/1381612819666131216114240","article-title":"The novel object recognition test in rodents in relation to cognitive impairment in schizophrenia","volume":"20","author":"Rajagopal","year":"2014","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2020.173685_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.108.150094","article-title":"Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders","volume":"329","author":"Roncarati","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173685_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/0976-500X.77113","article-title":"Protocol for middle cerebral artery occlusion by an intraluminal suture method","volume":"2","author":"Rupadevi","year":"2011","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.ejphar.2020.173685_bib50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1124\/jpet.113.210963","article-title":"Characterization of RO5126946, a Novel alpha7 nicotinic acetylcholine receptor-positive allosteric modulator","volume":"350","author":"Sahdeo","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173685_bib51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.pbb.2009.09.022","article-title":"Melatonin alleviates memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats","volume":"94","author":"Saxena","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2020.173685_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1601-183X.2007.00323.x","article-title":"Novel alpha7 nicotinic receptor isoforms and deficient cholinergic transcription in schizophrenia","volume":"7","author":"Severance","year":"2008","journal-title":"Gene Brain Behav."},{"issue":"3","key":"10.1016\/j.ejphar.2020.173685_bib53","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1021\/acs.jmedchem.9b01569","volume":"63","author":"Sinha","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173685_bib54","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s002130050573","article-title":"Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice","volume":"136","author":"Stevens","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2020.173685_bib55","article-title":"A type-II positive allosteric modulator of alpha7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats","volume":"8","author":"Sun","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173685_bib56","doi-asserted-by":"crossref","first-page":"3804979","DOI":"10.1155\/2018\/3804979","article-title":"Free radical damage in ischemia-reperfusion injury: an obstacle in acute ischemic stroke after revascularization therapy","author":"Sun","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ejphar.2020.173685_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1471-4159.2012.07876.x","article-title":"Type I and II positive allosteric modulators differentially modulate agonist-induced up-regulation of alpha7 nicotinic acetylcholine receptors","volume":"123","author":"Thomsen","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2020.173685_bib58","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/138161210790170094","article-title":"Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology","volume":"16","author":"Thomsen","year":"2010","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2020.173685_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027014","article-title":"Differential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in rats","volume":"6","author":"Thomsen","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173685_bib60","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.107.120436","article-title":"An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo","volume":"323","author":"Timmermann","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173685_bib61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.9758\/cpn.2018.16.1.7","article-title":"Cognitive deficits in schizophrenia: understanding the biological correlates and remediation strategies","volume":"16","author":"Tripathi","year":"2018","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"Suppl. 5","key":"10.1016\/j.ejphar.2020.173685_bib62","doi-asserted-by":"crossref","first-page":"v2","DOI":"10.1136\/jnnp.2005.082867","article-title":"Epidemiology and risk factors of dementia","volume":"76","author":"van der Flier","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejphar.2020.173685_bib63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbr.2017.07.001","article-title":"Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat","volume":"333","author":"Wadenberg","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2020.173685_bib64","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/14728222.2013.736498","article-title":"Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia","volume":"17","author":"Wallace","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2020.173685_bib65","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/jpet.110.171892","article-title":"RG3487, a novel nicotinic alpha7 receptor partial agonist, improves cognition and sensorimotor gating in rodents","volume":"336","author":"Wallace","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173685_bib66","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/schbul\/sbv072","article-title":"Phase 2 trial of an alpha-7 nicotinic receptor agonist (TC-5619) in negative and cognitive symptoms of schizophrenia","volume":"42","author":"Walling","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ejphar.2020.173685_bib67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/7854_2020_140","article-title":"Activators of alpha7 nAChR as potential therapeutics for cognitive impairment","volume":"45","author":"Wang","year":"2020","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.ejphar.2020.173685_bib68","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1124\/mol.111.074302","article-title":"Investigation of the molecular mechanism of the alpha7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states","volume":"80","author":"Williams","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173685_bib69","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.bcp.2013.06.031","article-title":"Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia","volume":"86","author":"Young","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173685_bib70","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1601-183X.2011.00711.x","article-title":"Delayed procedural learning in alpha7-nicotinic acetylcholine receptor knockout mice","volume":"10","author":"Young","year":"2011","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.ejphar.2020.173685_bib71","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1176\/appi.ajp.2012.11081289","article-title":"Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia","volume":"169","author":"Zhang","year":"2012","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejphar.2020.173685_bib72","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.1007\/s12035-016-0310-8","article-title":"Activation of alpha-7 nicotinic acetylcholine receptor reduces brain edema in mice with ischemic stroke and bone fracture","volume":"54","author":"Zou","year":"2017","journal-title":"Mol. Neurobiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920307779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920307779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:44:56Z","timestamp":1757976296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920307779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":71,"alternative-id":["S0014299920307779"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173685","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LL-00066471, a novel positive allosteric modulator of \u03b17 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173685"}}